›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies

Early stage IT and Healthcare Investing

Steve James

Steve James



"Labrys takes a lower risk approach to drug development with a promising clinical stage asset which addresses a significant medical need – chronic migraine. We have the opportunity to take LBR-101 deep into development and build the greatest value—a vision that is shared and supported by IW."
Steve James, President and CEO

Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine. Labrys' lead candidate, LBR-101 (formerly known as RN-307), is an anti-CGRP monoclonal antibody which has completed Phase 1.

Facebook Google+ Twitter Email LinkedIn Share